Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2011-000988-28Phase 4Completed
Phase 4, randomised, double-blind trial in bone fracture (Fx) and impaired fracture healing (IFH) comparing Alendronic acid with Placebo (2 arms). Primary endpoint: Fracture healing at 4 weeks. Started Aug 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2011-000988-28.